Biomerica(BMRA)
$1.10+0.01 (+0.92%)
BMRA
Biomerica financials statements
$1.10
At close:+0.01 (+0.92%)
Want to see BMRA full AI Analyst Report?
Biomerica (BMRA) Ratios
402 Followers
Biomerica Ratios
BMRA's free cash flow for Q4 2026 was $-949.00K. For the 2026 fiscal year, BMRA's free cash flow was decreased by $-37.00K and operating cash flow was $-912.00K. See a summary of the company’s cash flow.
| Ratios | Aug 26 | May 25 | May 24 | May 23 | May 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.62 | 2.80 | 3.51 | 6.58 | 4.69 |
| Quick Ratio | 0.93 | 1.95 | 2.43 | 5.52 | 3.49 |
| Cash Ratio | 0.53 | 1.38 | 1.89 | 5.00 | 2.94 |
| Solvency Ratio | -0.81 | -2.49 | -2.10 | -2.49 | -1.29 |
| Operating Cash Flow Ratio | -1.38 | -2.21 | -2.43 | -2.81 | -0.24 |
| Short-Term Operating Cash Flow Coverage | -6.84 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -113.00K | $ 3.04M | $ 5.07M | $ 10.07M | $ 6.38M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.35 | 0.08 | 0.08 | 0.07 | 0.12 |
| Debt-to-Equity Ratio | 0.91 | 0.11 | 0.12 | 0.09 | 0.17 |
| Debt-to-Capital Ratio | 0.48 | 0.10 | 0.11 | 0.08 | 0.14 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.57 | 1.45 | 1.40 | 1.23 | 1.37 |
| Debt Service Coverage Ratio | -9.84 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.82 | 0.20 | 0.05 | 0.08 | 0.11 |
| Net Debt to EBITDA | -0.22 | 0.42 | 0.56 | 1.26 | 1.15 |
| Profitability Margins | |||||
| Gross Profit Margin | 8.13% | 9.38% | 11.28% | 8.35% | 15.78% |
| EBIT Margin | -119.47% | -93.62% | -117.58% | -135.29% | -24.03% |
| EBITDA Margin | -110.02% | -86.09% | -110.67% | -128.71% | -20.87% |
| Operating Profit Margin | -119.47% | -96.72% | -117.58% | -135.29% | -24.03% |
| Pretax Profit Margin | -84.26% | -93.62% | -109.62% | -132.78% | -23.88% |
| Net Profit Margin | -84.77% | -93.64% | -110.40% | -133.73% | -24.01% |
| Continuous Operations Profit Margin | -84.77% | -93.64% | -110.40% | -133.73% | -24.01% |
| Net Income Per EBT | 100.61% | 100.02% | 100.71% | 100.72% | 100.53% |
| EBT Per EBIT | 70.53% | 96.79% | 93.23% | 98.14% | 99.41% |
| Return on Assets (ROA) | -55.85% | -83.65% | -64.60% | -49.40% | -39.84% |
| Return on Equity (ROE) | -143.54% | -121.14% | -90.70% | -60.90% | -54.43% |
| Return on Capital Employed (ROCE) | -124.36% | -122.16% | -90.31% | -57.74% | -48.42% |
| Return on Invested Capital (ROIC) | -106.12% | -112.58% | -86.32% | -56.40% | -46.72% |
| Return on Tangible Assets | -57.63% | -86.99% | -66.11% | -49.97% | -40.44% |
| Earnings Yield | -54.88% | -70.98% | -7.66% | -4.60% | -1.28% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.67 | 7.27 | 5.72 | 7.39 | 24.39 |
| Payables Turnover | 10.85 | 16.32 | 16.68 | 14.22 | 21.60 |
| Inventory Turnover | 2.40 | 3.23 | 2.02 | 2.38 | 6.58 |
| Fixed Asset Turnover | 2.28 | 9.42 | 5.74 | 4.28 | 12.45 |
| Asset Turnover | 0.66 | 0.89 | 0.59 | 0.37 | 1.66 |
| Working Capital Turnover Ratio | 1.91 | 1.23 | 0.66 | 0.58 | 2.46 |
| Cash Conversion Cycle | 183.01 | 140.86 | 222.48 | 177.07 | 53.55 |
| Days of Sales Outstanding | 64.34 | 50.24 | 63.83 | 49.36 | 14.97 |
| Days of Inventory Outstanding | 152.30 | 113.00 | 180.52 | 153.37 | 55.48 |
| Days of Payables Outstanding | 33.64 | 22.37 | 21.88 | 25.66 | 16.90 |
| Operating Cycle | 216.64 | 163.23 | 244.36 | 202.73 | 70.45 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.17 | -1.67 | -0.32 | -0.39 | -0.04 |
| Free Cash Flow Per Share | -1.17 | -1.69 | -0.33 | -0.39 | -0.05 |
| Dividend Paid and CapEx Coverage Ratio | -3421.00 | -103.81 | -46.62 | -70.18 | -2.82 |
| Capital Expenditure Coverage Ratio | -3421.00 | -103.81 | -46.62 | -70.18 | -2.82 |
| Operating Cash Flow Coverage Ratio | -1.44 | -8.39 | -6.83 | -5.06 | -0.35 |
| Operating Cash Flow to Sales Ratio | -0.77 | -0.72 | -0.99 | -1.03 | -0.03 |
| Free Cash Flow Yield | -49.73% | -55.35% | -7.02% | -3.58% | -0.18% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.82 | -1.41 | -13.06 | -21.73 | -78.32 |
| Price-to-Sales (P/S) Ratio | 1.54 | 1.32 | 14.41 | 29.06 | 18.80 |
| Price-to-Book (P/B) Ratio | 2.62 | 1.71 | 11.84 | 13.23 | 42.63 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.01 | -1.81 | -14.25 | -27.94 | -545.20 |
| Price-to-Operating Cash Flow Ratio | -2.01 | -1.82 | -14.56 | -28.34 | -738.45 |
| Price-to-Earnings Growth (PEG) Ratio | 0.05 | -0.00 | 0.47 | -0.56 | 2.35 |
| Enterprise Value Multiple | -1.62 | -1.11 | -12.46 | -21.32 | -88.93 |
| Enterprise Value | 7.95M | 5.07M | 74.67M | 146.49M | 350.31M |
| EV to EBITDA | -1.62 | -1.11 | -12.46 | -21.32 | -88.93 |
| EV to Sales | 1.79 | 0.95 | 13.79 | 27.44 | 18.56 |
| EV to Free Cash Flow | -2.33 | -1.31 | -13.64 | -26.39 | -538.23 |
| EV to Operating Cash Flow | -2.33 | -1.32 | -13.93 | -26.76 | -729.01 |
| Tangible Book Value Per Share | 0.83 | 1.69 | 0.38 | 0.82 | 0.64 |
| Shareholders’ Equity Per Share | 0.90 | 1.79 | 0.39 | 0.83 | 0.66 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.00 | -0.01 | -0.01 | -0.01 |
| Revenue Per Share | 1.53 | 2.31 | 0.32 | 0.38 | 1.49 |
| Net Income Per Share | -1.30 | -2.16 | -0.36 | -0.50 | -0.36 |
| Tax Burden | 1.01 | 1.00 | 1.01 | 1.01 | 1.01 |
| Interest Burden | 0.71 | 1.00 | 0.93 | 0.98 | 0.99 |
| Research & Development to Revenue | 0.18 | 0.19 | 0.28 | 0.30 | 0.10 |
| SG&A to Revenue | 1.10 | 0.87 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.11 | 0.09 | 0.15 | 0.22 | 0.07 |
| Income Quality | 0.91 | 0.77 | 0.90 | 0.77 | 0.11 |
Currency in USD

